Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific; DNA-binding transcription repressor activity, RNA polymerase II-specific; and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Acts upstream of or within cell fate determination; enteroendocrine cell differentiation; and negative regulation of epithelial cell differentiation. Predicted to be active in nucleus. Is expressed in several structures, including central nervous system; ear; and gut. Orthologous to human NKX6-3 (NK6 homeobox 3).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.